Lord, Abbett & Co’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
ACH
EWM
DM
OM
Lord, Abbett & Co's AXGN Position: Q1 2019 in Review
Lord, Abbett & Co sold out of Axogen (AXGN) in Q1 2019, closing a stake of 106,905 shares — an estimated $2.18M sold.
Lord, Abbett & Co first reported a position in AXGN in Q4 2017 and held it in 5 quarters. The position peaked at $17.8M in Q2 2018. 141 funds tracked by Wall St. Rank hold AXGN as of Q1 2019.
- Lord, Abbett & Co reported no remaining Axogen position as of Q1 2019 after selling out during the quarter.
- Lord, Abbett & Co sold 106,905 Axogen shares in Q1 2019, an estimated $2.18M.
- Lord, Abbett & Co first reported a position in Axogen in Q4 2017 and held it in 5 quarters.
- Lord, Abbett & Co's Axogen position peaked at $17.8M in Q2 2018.
- 141 funds tracked by Wall St. Rank held Axogen as of Q1 2019.
Based on Lord, Abbett & Co's 13F filing for Q1 2019, filed 15 May 2019.